Repolar Pharmaceuticals Ltd specializes in the research, development, production, and marketing of advanced preparations designed for the effective treatment of bacterial and fungal inflammations affecting wounds, skin, and nails. Founded in 2006, Repolar Pharmaceuticals Ltd leverages the unique properties of components refined from the resin of the Finnish forest spruce (Picea abies) to create innovative healthcare solutions.
Located with its headquarters and production facilities in Espoo, Repolar Pharmaceuticals Ltd is dedicated to enhancing patient care through its commitment to quality and innovation. The company's membership in the Finnish Family Firms Association underscores its dedication to ethical business practices and community involvement. Repolar Pharmaceuticals Ltd is committed to delivering cutting-edge medical solutions.
Operating from its primary address at Tietäjäntie 12 B, Espoo, FI-02130, FI, Repolar Pharmaceuticals Ltd continues to expand its reach and impact in the medical field. We invite the manager of Repolar Pharmaceuticals Ltd to create a customized and exclusive company showcase and product listing on our platform to further highlight their exceptional work.
Other organizations in the same industry
This company is also known as